Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 2,607 shares at $15.09 ($40K) on 2022-10-28, disclosed to the SEC on 2022-10-28.
Scheduled sale ($40k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.36 | 924 | $14K | 35.8% |
| 2 | $15.09 | 1,683 | $25K | 64.2% |
| Total | $15.19 avg | 2,607 | $40K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |